Products for Research Use Only

[Ru (dpp) (bpy) (mtmp) ] (PF6) 2

CAT: 0804-HY-176859Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-176859Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
[Ru (dpp) (bpy) (mtmp) ] (PF6) 2 (Compound 5) is a trisheteroleptic ruthenium complex. [Ru (dpp) (bpy) (mtmp) ] (PF6) 2 has a light-activated anticancer activity. [Ru (dpp) (bpy) (mtmp) ] (PF6) 2 can selectively cleave off upon green light irradiation, thereby releasing a phototoxic ruthenium-based photoproduct that binds to nuclear DNA, induces DNA damage and apoptosis in cancer cells. [Ru (dpp) (bpy) (mtmp) ] (PF6) 2 can be used for phototherapy of cancers like conjunctival melanoma research[1].
UNSPSC
12352005
Target
Apoptosis
Related Pathways
Apoptosis
Applications
Cancer-programmed cell death
Field of Research
Cancer
Smiles
C[S]1CC2=CC=CC=[N]2[Ru+2]134(OC(C(O4)=O)=O)[N]5=CC=C(C6=CC=CC=C6)C7=CC=C(C(C8=CC=CC=C8)=CC=[N]93)C9=C75.F[P-](F)(F)(F)(F)F.F[P-](F)(F)(F)(F)F
Molecular Formula
C33H25F12N3O4P2RuS
Molecular Weight
950.63
References & Citations
[1]Chen Q, et al. Photosubstitution in a trisheteroleptic ruthenium complex inhibits conjunctival melanoma growth in a zebrafish orthotopic xenograft model. Chem Sci. 2022 May 16;13 (23) :6899-6919.
Shipping Conditions
Room temperature
Scientific Category
Reference compound2
Clinical Information
No Development Reported